Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 9649291 Treatment for obesity
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
December 1, 2015
0
Date of Patent
May 16, 2017
0
Patent Application Number
14955646
0
Patent Citations Received
US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
US Patent 11998639 Formulations of (R)-2-amino-3-phenylpropyl carbamate
0
US Patent 12109186 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
US Patent 12115142 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
US Patent 12115143 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
0
US Patent 11766418 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US Patent 11779557 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US Patent 11839598 Methods of providing solriamfetol therapy to subjects with impaired renal function
0
•••
Patent Inventor Names
Gary Bream
0
Moise A. Khayrallah
0
Stephen E. Butts
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
9649291
0
Patent Primary Examiner
Paul V Ward
0
Find more entities like US Patent 9649291 Treatment for obesity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE